CardioGenics Holdings Inc
OTC:CGNH

Watchlist Manager
CardioGenics Holdings Inc Logo
CardioGenics Holdings Inc
OTC:CGNH
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 96.1 USD

CardioGenics Holdings Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CardioGenics Holdings Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
CardioGenics Holdings Inc
OTC:CGNH
EPS (Diluted)
$0
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
33%
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$1
CAGR 3-Years
-44%
CAGR 5-Years
-20%
CAGR 10-Years
-2%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$6
CAGR 3-Years
35%
CAGR 5-Years
45%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$12
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$14
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$42
CAGR 3-Years
-4%
CAGR 5-Years
9%
CAGR 10-Years
24%
No Stocks Found

CardioGenics Holdings Inc
Glance View

Market Cap
96.1 USD
Industry
Biotechnology

CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2004-06-09. The firm has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

CGNH Intrinsic Value
Not Available

See Also

What is CardioGenics Holdings Inc's EPS (Diluted)?
EPS (Diluted)
-0 USD

Based on the financial report for Jan 31, 2016, CardioGenics Holdings Inc's EPS (Diluted) amounts to -0 USD.

What is CardioGenics Holdings Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
33%

Over the last year, the EPS (Diluted) growth was 80%. The average annual EPS (Diluted) growth rates for CardioGenics Holdings Inc have been 21% over the past three years , 24% over the past five years , and 33% over the past ten years .

Back to Top